8/7/2020  5:30:19 PM Chg. +0.70 Volume Bid9:20:02 PM Ask5:40:00 PM Market Capitalization Dividend Y. P/E Ratio
68.60CHF +1.03% 43,961
Turnover: 2.88 mill.
68.65Bid Size: 30 68.65Ask Size: 180 3.84 bill.CHF 4.91% 5.66

Business description

BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
 

Management board & Supervisory board

CEO
Dr. Daniel Koller
Management board
Claude Mikkelsen, Dallas Webb, Dr. Christian Koch, Dr. Maurizio Bernasconi, Dr. Stephen Taubenfeld, Maria-Grazia Iten-Alderuccio, Rudy Le Blanc
Supervisory board
Dr. Erich Hunziker, Dr. Clive Meanwell, Dr. Thomas von Planta, Prof. Dr. Mads Krogsgaard Thomsen
 

Company data

Name: BB Biotech AG
Address: Seestraße 16,CH-8700 Küsnacht/Zürich
Phone: +41-44-26767-00
Fax: +41-44-26767-01
E-mail: info@bellevue.ch
Internet: www.bbbiotech.com
Industry: -
Sector: -
Sub sector: -
End of financial year: 12/31
Free Float: 96.47%
IPO date: 12/10/1997

Investor relations

Name: Dr. Silvia Schanz
IR phone: +41-44-26772-66
IR Fax: -
IR e-mail: ssc@bellevue.ch

Company calendar

CW 43 | 10/23/2020 Interim Report 3rd Quarter/9 Months
CW 8 | 2/19/2021 4th Quarter/Annual Report
CW 12 | 3/18/2021 General Shareholder Meeting
CW 17 | 4/23/2021 Interim Report 1st Quarter/3 Months
CW 30 | 7/23/2021 Interim Report 2nd Quarter/6 Months
 

Main Shareholders